UPDATED August 10, 2016, with information on the pricing and closing date for the offering. A pair of private equity players are readying an offering of Zimmer Biomet (NYSE:ZBH) shares that could be worth nearly $1 billion. Warsaw, Ind.-based Zimmer Biomet said KKR and TPG Capital are planning to sell more than 7.4 million ZBH shares at […]
Venture Capital/Private Equity
Private equity shop RoundTable Healthcare closes $140m Symmetry Surgical buy
RoundTable Healthcare Partners said this week that it closed the $140.3 million buyout of Symmetry Surgical, the legacy business formed after Symmetry Medical sold its orthopedics OEM operation to Tecomet in 2014. Nashville-based Symmetry Surgical makes reusable, reposable and single-use surgical instrumentation and specialty devices. The Lake Forest, Ill.-based private equity shop said it plans to leave president & CEO […]
Medtronic, Cochlear get in on $51m Earlens round
Earlens said today that it raised a funding round worth $51 million for the light-driven hearing aid it developed, pulling down $34 million in cash and another $17 million in a bridge financing conversion. The Earlens device, which last October won 510(k) clearance from the FDA, uses a laser diode attached to a behind-the-ear audio processor to […]
EQT deals Atos Medical to PE shop for $946m
(Reuters) — Swedish buyout house EQT said yesterday that it sold its medical device business, Atos Medical, to private equity firm PAI Europe, with sources valuing the deal at about €850 million ($946 million). PAI Europe won the bid for Atos, which makes voice implants, EQT said in a statement, but the 2 parties agreed not to […]
SV Life Sciences’ 6th fund pulls in $274m
SV Life Sciences said it raised $274 million of the $400 million it hopes to put into its 6th fund for investing in healthcare companies. The Boston-based venture capital shop said in a regulatory filing that 24 unnamed investors participated in the round, which began in May 2015. SV Life Sciences, which has some $1.9 billion […]
MVM Life Science Partners closes $233m healthcare fund
MVM Life Science Partners said it plans to use the $233 million it raised for its 4th fund to invest in medical companies in the U.S. and Europe. The Boston-and-London-based investment shop said the fund is its largest so far. MVM said it backs public and private companies at every stage of development, with investments of between […]
Private equity shop RoundTable Healthcare picks up Symmetry Surgical for $140m
RoundTable Healthcare Partners said it paid $140.3 million for Symmetry Surgical, the legacy business formed after Symmetry Medical sold its orthopedics OEM operation to Tecomet in 2014. Nashville-based Symmetry Surgical makes reusable, reposable and single-use surgical instrumentation and specialty devices. RoundTable said it expects to close the deal late in the 2nd quarter or early in the […]
Forbion Capital Partners launches $208m life sciences fund
European venture capital shop Forbion Capital Partners said today that it raised a $208 million fund it plans to use for investments in medical device, drug and diagnostic companies. The €183 million fund’s limited partners included strategic investors Charles River Laboratories and Knight Therapeutics, plus the European Investment Fund, the Dutch Venture Initiative, Germany’s KfW development bank, other regional investment […]
Goldman Sachs gets in on Chinese cardiac valve maker Venus Medtech
Chinese replacement heart valve maker Venus Medtech said today that it won a $37 million commitment from Goldman Sachs (NYSE:GS). Hangzhou-based Venus said it’s also won backing from Qiming Venture Partners, Sequoia Capital China, and Dinova Venture Capital. The company already has a transcatheter aortic valve replacement on the market in the People’s Republic and said a pulmonary […]
Frazier Healthcare raises $525m fund
Private equity shop Frazier Healthcare Partners said yesterday that it raised a $525 million fund to invest in small healthcare companies. The Seattle-based company, which has more than $2 billion in assets under management, said the subscribers include existing and new limited partners, which represent some endowments, public and private pension funds and financial institutions. The new fund […]
Spirox closes $45m Series C for ENT devices
Spirox said today that it closed the books on a Series C round worth $45 million for the new device it’s developing to treat nasal obstructions. Spirox, which pulled down an $18.5 million Series B nearly a year ago, said the latest round was led by private equity giant KKR and joined by new investor HealthQuest […]